Elevated IL-6 concentrations have been observed in individuals with depression [51,52,53], and some studies have additionally reported increased levels of IL-6 and its receptor antagonist in patients with treatment-resistant MDD [54,55]. Here, IL6 is linked to depressive symptom measurement.